Brexit Checklist for the Pharma Industry

by John Cahill Director/Snr Consultant, Quality and Compliance A disorderly Brexit is moving from a possibility to a probability. While governments pass last minute legislation over the month of March, it is encouraging to be part of a responsible industry that treats the threat to patients very seriously and has, according to our government officials, prepared very […]